Discover
APGE
Apogee Therapeutics, Inc.
135.07
2 x 96.59
2 x 171.87
bid
ask
+
0.00
0.00%
2 @ 04:00 PM
135.11 +0.04 (0.03%)
| Ytd | 78.95% | |
| 1y | 256.76% |
135.06
day range
135.09
35.39
52 week range
135.09
| Open | 135.06 | Prev Close | 135.07 | Low | 135.06 | High | 135.09 | Mkt Cap | 10.22B |
| Vol | 0.00 | Avg Vol | 2.95M | EPS | -4.34 | P/E | N/A | Forward P/E | -26.00 |
| Beta | 0.33 | Short Ratio | 3.63 | Inst. Own | 110.80% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-09 | 50-d Avg | 134.18 | 200-d Avg | 93.12 | 1yr Est | 134.62 |
| Income Statement | |||
| Operating Expenses | 96.00M | ||
| Research and Development Expense | 67.30M | ||
| Selling, General and Administrative Expense | 24.34M | ||
| Operating Income | -96.00M | ||
| Interest Expense | 1.58M | ||
| Income Tax Expense | 78.00K | ||
| Net Income | -85.85M | ||
| Net Income Common Stock | -85.85M | ||
| Net Income Common Stock (USD) | -85.85M | ||
| Consolidated Income | -85.85M | ||
| Earnings per Basic Share | -1.14 | ||
| Earnings per Basic Share (USD) | -1.14 | ||
| Earnings per Diluted Share | -1.14 | ||
| Earning Before Interest & Taxes (EBIT) | -84.20M | ||
| Earning Before Interest & Taxes (USD) | -84.20M | ||
| Weighted Average Shares | 75.44M | ||
| Weighted Average Shares Diluted | 75.44M | ||
| Balance Sheet | |||
| Cash and Equivalents | 105.57M | ||
| Cash and Equivalents (USD) | 105.57M | ||
| Investments | 1.19B | ||
| Investments Current | 866.36M | ||
| Investments Non-Current | 321.94M | ||
| Current Assets | 991.73M | ||
| Property, Plant & Equipment Net | 11.53M | ||
| Total Assets | 1.34B | ||
| Debt Current | 2.37M | ||
| Total Debt | 6.83M | ||
| Current Liabilities | 37.51M | ||
| Debt Non-Current | 4.47M | ||
| Total Liabilities | 141.21M | ||
| Accumulated Retained Earnings (Deficit) | -721.72M | ||
| Accumulated Other Comprehensive Income | -2.50M | ||
| Shareholders Equity | 1.19B | ||
| Shareholders Equity (USD) | 1.19B | ||
| Assets Non-Current | 344.08M | ||
| Total Debt (USD) | 6.83M | ||
| Liabilities Non-Current | 103.70M | ||
| Trade and Non-Trade Payables | 3.08M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.41M | ||
| Net Cash Flow from Financing | 107.02M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -346.23M | ||
| Capital Expenditure | 6.00K | ||
| Issuance (Purchase) of Equity Shares | 9.27M | ||
| Issuance (Repayment) of Debt Securities | 97.75M | ||
| Net Cash Flow from Investing | -381.86M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -381.87M | ||
| Net Cash Flow from Operations | -71.38M | ||
| Share Based Compensation | 16.66M | ||